Neuromodulation

Global Market Trajectory & Analytics

MCP13576

EXECUTIVE ENGAGEMENTS

OUTREACH

10472
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

1256
Interactions with Platform & by Email

PARTICIPANTS

314
Unique # Participated

VALIDATIONS

76
Responses Validated*

COMPETITORS

47
Responses Validated*
* Login for a full stack data experience

DATE

APR 2021

TABLES

84

PAGES

161

EDITION

8

PRICE

USD $4950


  

HIGHLIGHTS

Amid the COVID-19 crisis, the global market for Neuromodulation estimated at US$7.8 Billion in the year 2020, is projected to reach a revised size of US$17.8 Billion by 2027, growing at a CAGR of 12.4% over the analysis period 2020-2027. Deep brain stimulation, one of the segments analyzed in the report, is projected to record a 11.2% CAGR and reach US$2.9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Sacral nerve stimulation segment is readjusted to a revised 12.8% CAGR for the next 7-year period.
The Neuromodulation market in the U.S. is estimated at US$2.3 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.1 Billion by the year 2027 trailing a CAGR of 12.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11% and 10.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 9.1% CAGR.
In the global Vagus nerve stimulation segment, USA, Canada, Japan, China and Europe will drive the 9.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.2 Billion in the year 2020 will reach a projected size of US$2.2 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$2.1 Billion by the year 2027.

SELECT PLAYERS

Abbott Laboratories; Aleva Neurotherapeutics SA; Bioness Inc.; Boston Scientific Corporation; EnteroMedics, Inc.; LivaNova PLC; Medtronic PLC; NeuroPace, Inc.; Nevro Corp.

SEGMENTS

» Application (Failed Back Syndrome, Chronic Pain, Depression, Gastroparesis, Migraine, Other Applications) » Technology (Deep brain stimulation, Sacral nerve stimulation, Vagus nerve stimulation, Spinal cord stimulation, Transcutaneous electrical nerve stimulation, Repetitive transcranial magnetic stimulation, Other Neurostimulators)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Neuromodulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Neuromodulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027
World Current & Future Analysis for Deep brain stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Deep brain stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Sacral nerve stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Sacral nerve stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Vagus nerve stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Vagus nerve stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Spinal cord stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Spinal cord stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Transcutaneous electrical nerve stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Transcutaneous electrical nerve stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Repetitive transcranial magnetic stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Repetitive transcranial magnetic stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Other Neurostimulators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Other Neurostimulators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Failed Back Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Failed Back Syndrome by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Chronic Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Chronic Pain by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Depression by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Depression by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Gastroparesis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Gastroparesis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Migraine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Migraine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
UNITED STATES
USA Current & Future Analysis for Neuromodulation by Technology - Deep brain stimulation, Sacral nerve stimulation, Vagus nerve stimulation, Spinal cord stimulation, Transcutaneous electrical nerve stimulation, Repetitive transcranial magnetic stimulation and Other Neurostimulators - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA 7-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Deep brain stimulation, Sacral nerve stimulation, Vagus nerve stimulation, Spinal cord stimulation, Transcutaneous electrical nerve stimulation, Repetitive transcranial magnetic stimulation and Other Neurostimulators for the Years 2020 & 2027
USA Current & Future Analysis for Neuromodulation by Application - Failed Back Syndrome, Chronic Pain, Depression, Gastroparesis, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA 7-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Failed Back Syndrome, Chronic Pain, Depression, Gastroparesis, Migraine and Other Applications for the Years 2020 & 2027
CANADA
Canada Current & Future Analysis for Neuromodulation by Technology - Deep brain stimulation, Sacral nerve stimulation, Vagus nerve stimulation, Spinal cord stimulation, Transcutaneous electrical nerve stimulation, Repetitive transcranial magnetic stimulation and Other Neurostimulators - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada 7-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Deep brain stimulation, Sacral nerve stimulation, Vagus nerve stimulation, Spinal cord stimulation, Transcutaneous electrical nerve stimulation, Repetitive transcranial magnetic stimulation and Other Neurostimulators for the Years 2020 & 2027
Canada Current & Future Analysis for Neuromodulation by Application - Failed Back Syndrome, Chronic Pain, Depression, Gastroparesis, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada 7-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Failed Back Syndrome, Chronic Pain, Depression, Gastroparesis, Migraine and Other Applications for the Years 2020 & 2027
JAPAN
Japan Current & Future Analysis for Neuromodulation by Technology - Deep brain stimulation, Sacral nerve stimulation, Vagus nerve stimulation, Spinal cord stimulation, Transcutaneous electrical nerve stimulation, Repetitive transcranial magnetic stimulation and Other Neurostimulators - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan 7-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Deep brain stimulation, Sacral nerve stimulation, Vagus nerve stimulation, Spinal cord stimulation, Transcutaneous electrical nerve stimulation, Repetitive transcranial magnetic stimulation and Other Neurostimulators for the Years 2020 & 2027
Japan Current & Future Analysis for Neuromodulation by Application - Failed Back Syndrome, Chronic Pain, Depression, Gastroparesis, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan 7-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Failed Back Syndrome, Chronic Pain, Depression, Gastroparesis, Migraine and Other Applications for the Years 2020 & 2027
CHINA
China Current & Future Analysis for Neuromodulation by Technology - Deep brain stimulation, Sacral nerve stimulation, Vagus nerve stimulation, Spinal cord stimulation, Transcutaneous electrical nerve stimulation, Repetitive transcranial magnetic stimulation and Other Neurostimulators - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China 7-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Deep brain stimulation, Sacral nerve stimulation, Vagus nerve stimulation, Spinal cord stimulation, Transcutaneous electrical nerve stimulation, Repetitive transcranial magnetic stimulation and Other Neurostimulators for the Years 2020 & 2027
China Current & Future Analysis for Neuromodulation by Application - Failed Back Syndrome, Chronic Pain, Depression, Gastroparesis, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China 7-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Failed Back Syndrome, Chronic Pain, Depression, Gastroparesis, Migraine and Other Applications for the Years 2020 & 2027
EUROPE
Europe Current & Future Analysis for Neuromodulation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Neuromodulation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027
Europe Current & Future Analysis for Neuromodulation by Technology - Deep brain stimulation, Sacral nerve stimulation, Vagus nerve stimulation, Spinal cord stimulation, Transcutaneous electrical nerve stimulation, Repetitive transcranial magnetic stimulation and Other Neurostimulators - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Deep brain stimulation, Sacral nerve stimulation, Vagus nerve stimulation, Spinal cord stimulation, Transcutaneous electrical nerve stimulation, Repetitive transcranial magnetic stimulation and Other Neurostimulators for the Years 2020 & 2027
Europe Current & Future Analysis for Neuromodulation by Application - Failed Back Syndrome, Chronic Pain, Depression, Gastroparesis, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Failed Back Syndrome, Chronic Pain, Depression, Gastroparesis, Migraine and Other Applications for the Years 2020 & 2027
FRANCE
France Current & Future Analysis for Neuromodulation by Technology - Deep brain stimulation, Sacral nerve stimulation, Vagus nerve stimulation, Spinal cord stimulation, Transcutaneous electrical nerve stimulation, Repetitive transcranial magnetic stimulation and Other Neurostimulators - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France 7-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Deep brain stimulation, Sacral nerve stimulation, Vagus nerve stimulation, Spinal cord stimulation, Transcutaneous electrical nerve stimulation, Repetitive transcranial magnetic stimulation and Other Neurostimulators for the Years 2020 & 2027
France Current & Future Analysis for Neuromodulation by Application - Failed Back Syndrome, Chronic Pain, Depression, Gastroparesis, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France 7-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Failed Back Syndrome, Chronic Pain, Depression, Gastroparesis, Migraine and Other Applications for the Years 2020 & 2027
GERMANY
Germany Current & Future Analysis for Neuromodulation by Technology - Deep brain stimulation, Sacral nerve stimulation, Vagus nerve stimulation, Spinal cord stimulation, Transcutaneous electrical nerve stimulation, Repetitive transcranial magnetic stimulation and Other Neurostimulators - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany 7-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Deep brain stimulation, Sacral nerve stimulation, Vagus nerve stimulation, Spinal cord stimulation, Transcutaneous electrical nerve stimulation, Repetitive transcranial magnetic stimulation and Other Neurostimulators for the Years 2020 & 2027
Germany Current & Future Analysis for Neuromodulation by Application - Failed Back Syndrome, Chronic Pain, Depression, Gastroparesis, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany 7-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Failed Back Syndrome, Chronic Pain, Depression, Gastroparesis, Migraine and Other Applications for the Years 2020 & 2027
ITALY
Italy Current & Future Analysis for Neuromodulation by Technology - Deep brain stimulation, Sacral nerve stimulation, Vagus nerve stimulation, Spinal cord stimulation, Transcutaneous electrical nerve stimulation, Repetitive transcranial magnetic stimulation and Other Neurostimulators - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy 7-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Deep brain stimulation, Sacral nerve stimulation, Vagus nerve stimulation, Spinal cord stimulation, Transcutaneous electrical nerve stimulation, Repetitive transcranial magnetic stimulation and Other Neurostimulators for the Years 2020 & 2027
Italy Current & Future Analysis for Neuromodulation by Application - Failed Back Syndrome, Chronic Pain, Depression, Gastroparesis, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy 7-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Failed Back Syndrome, Chronic Pain, Depression, Gastroparesis, Migraine and Other Applications for the Years 2020 & 2027
UNITED KINGDOM
UK Current & Future Analysis for Neuromodulation by Technology - Deep brain stimulation, Sacral nerve stimulation, Vagus nerve stimulation, Spinal cord stimulation, Transcutaneous electrical nerve stimulation, Repetitive transcranial magnetic stimulation and Other Neurostimulators - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK 7-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Deep brain stimulation, Sacral nerve stimulation, Vagus nerve stimulation, Spinal cord stimulation, Transcutaneous electrical nerve stimulation, Repetitive transcranial magnetic stimulation and Other Neurostimulators for the Years 2020 & 2027
UK Current & Future Analysis for Neuromodulation by Application - Failed Back Syndrome, Chronic Pain, Depression, Gastroparesis, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK 7-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Failed Back Syndrome, Chronic Pain, Depression, Gastroparesis, Migraine and Other Applications for the Years 2020 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for Neuromodulation by Technology - Deep brain stimulation, Sacral nerve stimulation, Vagus nerve stimulation, Spinal cord stimulation, Transcutaneous electrical nerve stimulation, Repetitive transcranial magnetic stimulation and Other Neurostimulators - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe 7-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Deep brain stimulation, Sacral nerve stimulation, Vagus nerve stimulation, Spinal cord stimulation, Transcutaneous electrical nerve stimulation, Repetitive transcranial magnetic stimulation and Other Neurostimulators for the Years 2020 & 2027
Rest of Europe Current & Future Analysis for Neuromodulation by Application - Failed Back Syndrome, Chronic Pain, Depression, Gastroparesis, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe 7-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Failed Back Syndrome, Chronic Pain, Depression, Gastroparesis, Migraine and Other Applications for the Years 2020 & 2027
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for Neuromodulation by Technology - Deep brain stimulation, Sacral nerve stimulation, Vagus nerve stimulation, Spinal cord stimulation, Transcutaneous electrical nerve stimulation, Repetitive transcranial magnetic stimulation and Other Neurostimulators - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific 7-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Deep brain stimulation, Sacral nerve stimulation, Vagus nerve stimulation, Spinal cord stimulation, Transcutaneous electrical nerve stimulation, Repetitive transcranial magnetic stimulation and Other Neurostimulators for the Years 2020 & 2027
Asia-Pacific Current & Future Analysis for Neuromodulation by Application - Failed Back Syndrome, Chronic Pain, Depression, Gastroparesis, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific 7-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Failed Back Syndrome, Chronic Pain, Depression, Gastroparesis, Migraine and Other Applications for the Years 2020 & 2027
REST OF WORLD
Rest of World Current & Future Analysis for Neuromodulation by Technology - Deep brain stimulation, Sacral nerve stimulation, Vagus nerve stimulation, Spinal cord stimulation, Transcutaneous electrical nerve stimulation, Repetitive transcranial magnetic stimulation and Other Neurostimulators - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of World 7-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Deep brain stimulation, Sacral nerve stimulation, Vagus nerve stimulation, Spinal cord stimulation, Transcutaneous electrical nerve stimulation, Repetitive transcranial magnetic stimulation and Other Neurostimulators for the Years 2020 & 2027
Rest of World Current & Future Analysis for Neuromodulation by Application - Failed Back Syndrome, Chronic Pain, Depression, Gastroparesis, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of World 7-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Failed Back Syndrome, Chronic Pain, Depression, Gastroparesis, Migraine and Other Applications for the Years 2020 & 2027
Total Companies Profiled: 47

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com